At a pivotal moment in cancer vaccine research, the MIT Koch Institute Annual Symposium explored emerging successes and obstacles in the field in areas that include immunology, next-generation tools and models, and mRNA and other vaccine platforms.
Nicole Henning, a research specialist at the Preclinical Imaging and Testing Core Facility at MIT's Koch Institute, has advanced medical research with her invention of USGI, an ultrasound imaging system for studying disease development.
MIT Koch Institute researchers develop a cancer treatment combining immune checkpoint blockade therapy with STING. The resulting vaccine eliminates most tumors and prevents recurrence in mice, with minimal side effects.
MIT’s Koch Institute for Integrative Cancer Research hosts Alejandro Aguilera Castrejón and Melanie de Alameida, the inaugural winners of the Angelika Amon Young Scientist Award.